Siemens and IMPAC Announce Five-Year Extension to Distribution Agreement Supporting Oncology Centers Around the World

STOCKHOLM, Sweden, Oct. 5, 2005 (PRIMEZONE) -- Siemens Medical Solutions and IMPAC Medical Systems Inc., part of the Elekta Group and a leading provider of information technology solutions for oncology care, today announced a five-year extension of their software distribution agreement, which enables Siemens to distribute its LANTIS(R) Oncology Information System, based upon IMPAC's integrated clinical and administrative management systems, to oncology practices worldwide.

Under the terms of the agreement, Siemens can package IMPAC's radiation oncology management software with its oncology treatment solutions to address the comprehensive needs of today's oncology departments, and will continue to cooperate in the development and marketing of IMPAC products.

"Our relationship with IMPAC has been in effect since 1992, and the fact that we will remain partners in oncology solutions is a testament to our willingness to work together to provide the oncology community with comprehensive solutions for clinical and administrative practice management," said Ajit Singh, PhD, president of Siemens Medical Solutions, Oncology Care Systems division. "Our current and future customers will continue to benefit from this agreement."

"IMPAC is pleased that we have extended our agreement with Siemens," stated James P. Hoey, IMPAC president and CEO, "and it is clear that both companies continue to fully embrace an open systems environment that enables our customers to pursue best-of-breed solutions. We encourage all manufacturers to do the same."

"Standards development and adoption are long overdue in radiation oncology and this partnership allows us to direct more of our development dollars towards the advancement of clinical solutions and less on maintaining compatibility with proprietary systems," noted Joseph K. Jachinowski, executive vice president of product creation for the Elekta Group.

For further information, please contact:

 Julie DeSantis Public Relations Manager, IMPAC Medical Systems, Inc.  
 650 623 8883, e-mail:

 Amanda Naiman,  Manager Media Relations, Siemens Medical Solutions 
 610 448-4531, e-mail:

 Investor inquiries: International 
 Peter Ejemyr Group VP Corporate Communications, Elekta AB 
  +46 733 611 000, e-mail:

 Investor inquiries: United States 
 Lars Jonsteg VP Investor Relations North America, Elekta, USA 
  +46 708 78 37 35, e-mail:

About Siemens Medical Solutions

Siemens Medical Solutions of Siemens AG (NYSE:SI) with headquarters in Malvern, Pennsylvania and Erlangen, Germany, is one of the largest suppliers to the healthcare industry in the world. The company is known for bringing together innovative medical technologies, healthcare information systems, management consulting, and support services, to help customers achieve tangible, sustainable, clinical and financial outcomes. Employing approximately 31,000 people worldwide and operating in more than 120 countries, Siemens Medical Solutions reported sales of 7.07 billion EUR, orders of 8.12 billion EUR and group profit of 1.05 billion EUR for fiscal 2004. More information can be obtained by visiting

About IMPAC Medical Systems, Inc.

IMPAC Medical Systems, Inc., a company in the Elekta Group, provides healthcare IT solutions that streamline clinical and business operations across the spectrum of cancer care. IMPAC's open integration to multiple healthcare data and imaging systems offers oncology-specific patient charting and practice management, as well as best-of-breed systems for anatomic pathology, clinical laboratory, and cancer registry. With products that range from diagnosis and treatment through long-term follow-up, IMPAC provides a comprehensive oncology management solution that helps improve overall communication, process efficiency, and quality patient care. For more information about IMPAC's products or services, please call 888-GO-IMPAC or visit

About Elekta

Elekta is an international medical-technology Group, providing meaningful clinical solutions, comprehensive information systems and services for improved cancer care and management of brain disorders. All of Elekta's solutions employ non-invasive or minimally invasive techniques and are therefore clinically effective, gentle on the patient and cost-effective. With approx. 1700 employees, Elekta's corporate headquarters is located in Stockholm, Sweden and the company is listed on the Stockholm Stock Exchange under the ticker EKTAb. For more information about Elekta's products or services, please visit

This information was brought to you by Waymaker The following files are available for download:

PDF version